$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How effective is Eltrombopag/Eltrombopag treatment? Are there any serious side effects?
2026-02-01 22:25:32
Check Details
Eltrombopag/eltrombopag principle
2026-02-01 22:25:32
Check Details
The best time to take Eltrombopag/Eltrombopag
2026-02-01 22:25:32
Check Details
Contraindications of Eltrombopag/Eltrombopag
2026-02-01 22:25:32
Check Details
What is tucatinib/tucatinib?
2026-02-01 22:25:32
Check Details
How effective is tucatinib/tucatinib in breast cancer?
2026-02-01 22:25:32
Check Details
When was tucatinib/tucatinib launched? Is it listed in China?
2026-02-01 22:25:32
Check Details
Correct usage and dosage of tucatinib/tucatinib, and how to use it?
2026-02-01 22:25:32
Check Details
What is the mechanism of action of tucatinib/tucatinib? How does it work?
2026-02-01 22:25:32
Check Details
Which company develops and produces tucatinib/tucatinib?
2026-02-01 22:25:32
Check Details
What are the side effects of tucatinib/tucatinib?
2026-02-01 22:25:32
Check Details
Tucatinib/tucatinib effects and efficacy
2026-02-01 22:25:32
Check Details
1
2
...
492
493
494
495
496
497
498
...
10237
10238
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
After Ibrutinib Resistance: CLL/SLL and MCL Next Steps, Progression vs Intolerance
2
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
3
Quizartinib for FLT3-ITD AML: Induction-Consolidation-Maintenance and QT Monitoring
4
Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer: FDA Accelerated Approval and AZUR-1
5
Ibrutinib for Mantle Cell Lymphoma: BTK Mechanism, Response Is Not Cure, Post-Resistance Options
6
Filgotinib JAK1 Inhibitor: RA and Ulcerative Colitis Dosing, Infection/Thrombosis Risks, Pregnancy Contraindication
7
Daprodustat for Dialysis CKD Anemia: HIF Mechanism, Thrombotic Black Box Warning, Blood Pressure and GI Monitoring
8
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring
9
Cabozantinib with Aspirin: Additive Bleeding Risk, Do Not Stop Cardiac Aspirin Alone, Urgent Warning Signs
10
Bosentan Key Prescribing Points: Indication, Dosage, Risks, and Monitoring
11
Ambrisentan and IgA Nephropathy: Does It Reduce Proteinuria and Is It Safe?
12
Stiripentol for Dravet Syndrome With Clobazam: Weight-Based Dosing, Food Administration, Somnolence and Blood Count Monitoring